✦ LIBER ✦

276 Phase I trial of low dose interferon-alpha (IFN), thalidomide with gemcitabine and capecitabine in patients with progressive metastatic renal cell carcinoma (RCC)

✍ Scribed by R. Amato; N. Thompson; F. Naveed

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase I clinical trial of low-dose int

✍ Robert J. Amato; Muhammad Khan 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 221 KB

857 Phase II study of low dose thalidomi

✍ S. Avishay; C. Sternberg; N. Yarom; T. Sava; F. Calabrò; G.L. Cetto 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 174 KB

A Phase I Trial of Weekly Gemcitabine an

✍ F. Perez-Zincer; T. Olencki; G.T. Budd; D. Peereboom; P. Elson; R.M. Bukowski 📂 Article 📅 2002 🏛 Springer US 🌐 English ⚖ 75 KB

Phase I trial of capecitabine in combina

✍ David Z. Chang; Thomas Olencki; Thomas G. Budd; David Peereboom; R. Ganapathi; B 📂 Article 📅 2001 🏛 Springer 🌐 English ⚖ 107 KB

Phase I trial of sorafenib in combinatio

✍ Masashi Niwakawa, Katsuyoshi Hashine, Raizo Yamaguchi, Hirofumi Fujii, Yasuo Ham 📂 Article 📅 2011 🏛 Springer US 🌐 English ⚖ 359 KB

Erratum to: Phase I trial of sorafenib i

✍ Masashi Niwakawa, Katsuyoshi Hashine, Raizo Yamaguchi, Hirofumi Fujii, Yasuo Ham 📂 Article 📅 2011 🏛 Springer US 🌐 English ⚖ 65 KB